Date published: 2026-5-4

1-800-457-3801

SCBT Portrait Logo
Seach Input

CapZIP Inhibitors

CapZIP inhibitors belong to a specific class of chemical compounds that have gained attention in the field of molecular biology and cellular transport research. CapZIP, also known as CAP-Gly domain-containing linker protein 2, is a protein that plays a critical role in intracellular transport and cytoskeleton organization. The term CapZIP inhibitors refers to a group of molecules meticulously designed to selectively target and modulate the activity of CapZIP. These inhibitors serve as essential tools in laboratory investigations, enabling researchers to explore the intricate molecular functions and cellular processes associated with CapZIP.

CapZIP inhibitors typically function by interfering with the interactions between CapZIP and its binding partners, such as microtubules or other cellular proteins. This interference can disrupt the normal process of intracellular transport and cytoskeleton organization, impacting various aspects of cellular function and morphology. Researchers employ CapZIP inhibitors to gain insights into the physiological roles and molecular interactions of CapZIP within cells, aiming to advance our understanding of the fundamental mechanisms involved in intracellular trafficking and cytoskeletal dynamics. Through the study of CapZIP inhibitors, scientists seek to unravel the complexities of cellular logistics, molecular motor proteins, and the broader field of cell biology, contributing to our knowledge of how cells precisely orchestrate intracellular transport and maintain their structural integrity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

K-252a

99533-80-9sc-200517
sc-200517B
sc-200517A
100 µg
500 µg
1 mg
$129.00
$214.00
$498.00
19
(2)

K-252a inhibits protein kinase C, which can phosphorylate and activate CREB, potentially leading to decreased CREB activity.

Naphthol AS

92-77-3sc-215536A
sc-215536
25 g
500 g
$42.00
$162.00
(1)

As a phosphatase inhibitor, it could prevent dephosphorylation of CREB, altering its function and potentially mimicking CapZIP inhibition.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

KN-93 is a calcium/calmodulin-dependent protein kinase II inhibitor, which could affect CREB phosphorylation and activity.

KN-62

127191-97-3sc-3560
1 mg
$136.00
20
(2)

KN-62 is another CaMKII inhibitor, which could lead to reduced phosphorylation of CREB and lower its transcriptional activity.

Ro 31-8220

138489-18-6sc-200619
sc-200619A
1 mg
5 mg
$92.00
$245.00
17
(1)

Ro 31-8220 is a protein kinase C inhibitor that may decrease CREB activity by preventing its phosphorylation.